APA (7th ed.) Citation

Baylan, B., Ulusoy, K., Ekenci, B., & Kartal, I. G. (2024). Can systemic immune-inflammation index and hematologic parameters aid in decision-making for active surveillance or curative treatment in low-risk prostate cancer? Elsevier.

Chicago Style (17th ed.) Citation

Baylan, Burhan, Kemal Ulusoy, Berk Ekenci, and Ibrahim Guven Kartal. Can Systemic Immune-inflammation Index and Hematologic Parameters Aid in Decision-making for Active Surveillance or Curative Treatment in Low-risk Prostate Cancer? Elsevier, 2024.

MLA (9th ed.) Citation

Baylan, Burhan, et al. Can Systemic Immune-inflammation Index and Hematologic Parameters Aid in Decision-making for Active Surveillance or Curative Treatment in Low-risk Prostate Cancer? Elsevier, 2024.